The CHA2DS2-VASc score better predicted atrial fibrillation (ROC 0.79) than the C2HEST (ROC 0.78) and HAVOC (ROC 0.77) scores in patients with rheumatological disease.
Observational
Yes
Does the CHA2DS2-VASc score predict atrial fibrillation better than C2HEST and HAVOC scores in patients with rheumatological disease?
The CHA2DS2-VASc score slightly outperforms the C2HEST and HAVOC scores in predicting incident atrial fibrillation among patients with rheumatological disorders.
Effect estimate: ROC 0.79
PURPOSE: This is a nationwide-based retrospective study aiming to compare the three different scoring systems (CHA2DS2-VASc, C2HEST and HAVOC scores) in the prediction of atrial fibrillation (AF) in patients with rheumatological disease. METHODS: We used the Fine and Gray model to estimate the risk of AF (subhazard ratio and 95% CI). The predictive accuracy and discriminatory ability of the predictive model were evaluated by receiver operating characteristic (ROC) curve. RESULTS: Among the three predictive models, the model using CHA2DS2-VASc score had the better discriminative ability with an ROC of 0.79. The model with C2HEST score had an ROC of 0.78. The discriminative ability of the HAVOC score was 0.77, estimated by ROC. CONCLUSION: We concluded the CHA2DS2-VASc score has better performance in predicting AF compared with C2HEST score or HAVOC score.
Hu et al. (Mon,) conducted a observational in Rheumatological disease. CHA2DS2-VASc score vs. C2HEST and HAVOC scores was evaluated on Prediction of atrial fibrillation (AF) (ROC 0.79). The CHA2DS2-VASc score better predicted atrial fibrillation (ROC 0.79) than the C2HEST (ROC 0.78) and HAVOC (ROC 0.77) scores in patients with rheumatological disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: